| Literature DB >> 21811512 |
Wei Wei Liu1, Yong Xiang Gao, Li Ping Zhou, Azure Duan, Ling Ling Tan, Wan Zhen Li, Min Yan, Hong Ya Yang, Shi Lin Yan, Mi Qu Wang, Wei Jun Ding.
Abstract
We have performed an analysis of a family with kidney-yang deficiency syndrome (KDS) in order to determine the structural genomic variations through a novel approach designated as "copy number variants" (CNVs). Twelve KDS subjects and three healthy spouses from this family were included in this study. Genomic DNA samples were genotyped utilizing an Affymetrix 100 K single nucleotide polymorphism array, and CNVs were identified by Copy Number Algorithm (CNAT4.0, Affymetrix). Our results demonstrate that 447 deleted and 476 duplicated CNVs are shared among KDS subjects within the family. The homologus ratio of deleted CNVs was as high as 99.78%. One-copy-duplicated CNVs display mid-range homology. For two copies of duplicated CNVs (CNV(4)), a markedly heterologous ratio was observed. Therefore, with the important exception of CNV(4), our data shows that CNVs shared among KDS subjects display typical Mendelian inheritance. A total of 113 genes with established functions were identified from the CNV flanks; significantly enriched genes surrounding CNVs may contribute to certain adaptive benefit. These genes could be classified into categories including: binding and transporter, cell cycle, signal transduction, biogenesis, nerve development, metabolism regulation and immune response. They can also be included into three pathways, that is, signal transduction, metabolic processes and immunological networks. Particularly, the results reported here are consistent with the extensive impairments observed in KDS patients, involving the mass-energy-information-carrying network. In conclusion, this article provides the first set of CNVs from KDS patients that will facilitate our further understanding of the genetic basis of KDS and will allow novel strategies for a rational therapy of this disease.Entities:
Year: 2011 PMID: 21811512 PMCID: PMC3136678 DOI: 10.1093/ecam/neq069
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Pedigree tree of the collected KDS family.
Figure 2The chromosome distribution of shared CNVs among KDS patients.
Statistic results of homologus and heterologous CNVs from a KDS family.
| Copy number(s) | Number of homologous CNVs (%) | Number of heterologous CNVs (%) |
|---|---|---|
| CNV = 0 | 12 (100) | 0 (0) |
| CNV = 1 | 433 (99.77) | 1 (0.23) |
| CNV = 3 | 278 (76.58) | 85 (23.42) |
| CNV = 4 | 20 (17.70) | 93 (82.30) |
Genes mined within 100 bp of the CNVs of a KDS family.
| CNV types | Functional class | Representative genes |
|---|---|---|
| Deleted CNVs | Binding and transporters | ZNF509, RNF150, DMRTC2, MYRIP, DDX26B, ZNF509, DMRTC2, ZNF509, MYRIP, FRMD4A, SCHIP1, DNAJC18, SDK1, CDH17, RP13-102H20.1, SLC5A9, MYRIP, ENTHD1 |
| Cell cycle | NEK7, PPP1R1C, MID1, FAM162A, RFC3, CTAGE5, RHOJ, CDC73, EIF4G3, CDKL1 | |
| signal transduction | SDK1, LPHN3, FNDC3B, HAND2, MDGA1, MATR3, DST, MDGA1, CRADD, ARHGEF1, PKIB, NRG1, PIK3AP, ARHGAP25, GRAP2 | |
| Immune response | C4orf7, CSN3, PROL1, GPX3, C1RL, GRAP2 | |
| Enlarged CNVs | Binding and transporters | ROR1, ERCC6, ALKBH8, C1orf83, KIAA0999, TUBA8, SLC28A2, LOC401898, KIAA2022, ZNF331, ZNF487, C1orf83, ELAC2, PCDH9, DNAJC3, LRRC50, ZNF208, LOC401898, LOC730087, ELAC2, CRB1, FSTL5, CDH19, TRPM3, TMTC1, SYT1, FSTL5, CPLX4, CDH19, DIAPH3, ERGIC2, LOC348751, COG2, SLC28A2 |
| Nervous development | ROR1, SEMA5A, SEMA5B, OPRM1, DYM, CNTN5, NTRK3, VIPR2, PCDH9 | |
| Metabolism regulation | AHCYL1, PTTG2, PRIM2, HPGD, HPSE2, ALKBH8, PNLIPRP3, MBTPS1 | |
| Biogenesis | SPATA5L1, ODF2, FMN1, SPTLC1, TBC1D1, HNT, MATN2, DGFC, GREM1, BMP | |
| Immune response | NTRK3, GPR177, ASTN2, CNTN5, GAB2, ELMOD1, DNAJC3, FER, HLA-DQB1 |
Pathways derived from the genes located in the CNV flanks of a KDS family.
| CNVs | Copy numbers | Related genes | Related pathways |
|---|---|---|---|
| rs2002594; rs1986617 | 1 | FAM162A | Mitochondrial apoptotic cascades |
| rs10517547; rs10517548; rs2122642; rs2345041; rs1823535; rs1823536; rs1470724 | 1 | LPHN3 | G-protein-coupled-receptor proteolysis |
| rs764223 | 1 | PGAM1 | Glycolysis/gluconeogenesis; metabolism of carbohydrates |
| rs137964; rs10483201 | 1 | GRAP2 | T cell receptor signaling pathway |
| rs10491333 | 4 | HLA-DQB1 | Antigen processing and presentation |
| rs2895201 | 4 | SPTLC1 | Sphingolipid metabolism |
| rs1988981; rs1321555; rs1358815; rs1964875; | 4 | PRIM2 | Purine and pyrimidine metabolism; telomere maintenance |
| rs3797819; rs10515399; rs1896582; rs1366081; rs9326759 | 4 | FER | Adherens junction |
| rs342597; rs10507638; rs10507639 | 3 | DIAPH3 | Regulation of actin cytoskeleton |
| rs10520675; rs10520671; rs7167737; rs1948066; rs10520673; rs965313 | 3 | NTRK3 | MAPK pathway |
| rs6816712; rs2911940; rs10517654; rs10517655; rs7662187; rs10517658 | 3 | PDGFC | Cytokine-cytokine receptor interaction; Focal adhesion; Gap junction |
| rs855858; rs855860; rs10489736 | 3 | ROR1 | transmembrane receptor protein tyrosine kinase signaling pathway |
| rs2912 | 3 | GAB2 | Fc epsilon RI signaling pathway |
| rs10491050; rs7092874; rs7904118 | 3 | SORCS1 | neuropeptide signaling pathway |
| rs10485060; rs9322451; rs1852629 | 3 | OPRM1 | Neuroactive ligand-receptor interaction |
| rs1060447; rs4919231; rs1932796; rs716838; rs2169462; rs10509722 | 3 | HPSE2 | Glycosaminoglycan degradation |
Figure 3A hypothetical diagram demonstrating the relationships between KDS patients and CNVs.